Nyla A Heerema, PhD
College of Medicine
Precursor Cell Lymphoblastic Leukemia-Lymphoma, Cancer, Leukemia, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Acute, Chromosome Aberrations, Down Syndrome, Cancer, Germ Cell and Embryonal, Trisomy, Burkitt Lymphoma
Nyla Heerema, PhD, is a member of the Leukemia Research Program at the OSUCCC – James, where she focuses her research on chromosomal abnormalities in hematologic malignancies.In particular, Dr. Heerema’s work involves studying chromosome changes in pediatric acute lymphoblastic leukemia, including the use of fluorescence in situ hybridization (FISH) for patient risk stratification in clinical trials of the Children’s Oncology Group (COG). She leads all cytogenetic studies for the COG, the world’s largest organization devoted exclusively to childhood and adolescent cancer research. She is also very involved in the cytogenetics of chronic lymphocytic leukemia (CLL). In addition to basic science investigations, she has conducted cytogenetics investigations for several national studies, including Alliance for Clinical Trials studies. Dr. Heerema is the co-author of many articles in well-known publications, such as Genetics in Medicine, British Journal of Haematology, Blood, Journal of Clinical Oncology and Pediatric Blood & Cancer.